$3.230
+0.125 (+3.86%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LXEO por análisis de gráficos similares
Alphio's LXEO stock price prediction model matches the current Lexeo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.22 (-0.29%). The 1-week path is $3.32 (+2.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Lexeo Therapeutics Inc?
Lexeo Therapeutics Inc is currently not a strong buy. The stock is priced at $3.06, significantly below its 52-week high of $10.99, indicating a potential for recovery but also substantial risk. The RSI is at 55.25, suggesting that the stock is neither overbought nor oversold, which may indicate a stable trend. However, the forward P/E ratio is 5.66, which is low, but the company has been consistently reporting negative net income, with a net loss of $25.9 million in Q4 2024 and a gross profit of $0 in that same quarter. The recent insider selling has increased by 271.82%, which raises concerns about insider confidence. The main risk is the ongoing losses, as evidenced by a projected EPS of -0.33 for the next earnings report on November 4, 2026.
LXEO cerró en $3.23 el Wednesday, tras subir +3.86%
Lexeo Therapeutics Inc (LXEO) last closed at $3.23, gaining +3.86%. These facts feed the 1-day and 1-week LXEO price prediction above.
Factores de la previsión
Los factores de la previsión de Lexeo Therapeutics Inc (LXEO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LXEO, ordenadas por similitud.
Análisis de estacionalidad de LXEO
Historically the probability of a positive November return for LXEO is 45.24%. December offers the highest probability of a positive month at 51.16%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LXEO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $4.78 | $4.96 | $5.32 | +53.41% |
| Dec 2026 | $3.70 | $4.02 | $4.36 | +24.53% |
En 2026, se proyecta que Lexeo Therapeutics Inc (LXEO) oscile entre $3.70 y $5.32.
Previsión mensual de Lexeo Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Lexeo Therapeutics Inc promedie $4.96, con un mínimo de $4.78 y un máximo de $5.32.
En Dec de 2026, se proyecta que Lexeo Therapeutics Inc promedie $4.02, con un mínimo de $3.70 y un máximo de $4.36.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.